Clinical Applications of Optical Coherence Tomography in Age-Related Macular Degeneration

  • J. Fernando Arevalo
  • Reinaldo A. Garcia

Optical coherence tomography (OCT) is a noninvasive, dynamic technology ideal for observing the natural course of age-related macular degeneration (AMD). The structural information provided by OCT is becoming a valuable diagnostic adjunct to fluorescein angiography (FA) and indocyanine green videoangiography (ICGV). The goal of using OCT is to correlate these observed structural changes with changes in visual acuity (VA), not only to better understand the mechanism of vision loss associated with AMD, but also to understand the mechanism of VA benefits attributed to various treatments. In particular, OCT is a valuable tool to monitor the treatment effects associated with photodynamic therapy (PDT) as well as periocular and intraocular pharmacologic therapy in neovascular AMD.1


Optical Coherence Tomography Retinal Pigment Epithelium Fluorescein Angiography Retinal Thickness Choroidal Neovascularization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mavrofrides EC, Villate N, Rosenfeld PJ, Puliafito CA. In: Schuman JS, Puliafito CA, Fujimoto JG, eds. Optical Coherence Tomography of Ocular Diseases: Age Related Macular Degeneration, 2nd ed. Thorofare, NJ: Slack, 2004:243–343.Google Scholar
  2. 2.
    Sarks SH, Sarks JP. In: Ryan SJ, ed. Retina: Age-Related Macular Degeneration: Atrophic Form, 2nd ed. St. Louis: Mosby, 1994:1071–1102.Google Scholar
  3. 3.
    Sarks SH, Sarks JP. In: Ryan SJ, ed. Retina: Age-Related Maculopathy: Nonneovascular Age Related Macular Degeneration and the Evolution of Geographic Atrophy, 3rd ed. St. Louis: Mosby, 2001:1064–1099.Google Scholar
  4. 4.
    Roquet W, Roudot-Thoraval F, Coscas G, Soubrane G. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br J Ophthalmol 2004;88:638–642.PubMedCrossRefGoogle Scholar
  5. 5.
    Hassenstein A, Ruhl R, Richard G. [Optical coherence tomography in geographic atrophy—a clinicopathologic correlation]. Klin Monatsbl Augenheilkd 2001;218:503–509.PubMedCrossRefGoogle Scholar
  6. 6.
    Bressler NM, Bressler SB, Fine SL. In: Ryan SJ, ed. Retina: Neo-vascular (Exudative) Age Related Macular Degeneration, 3rd ed. St. Louis: Mosby, 2001:1100–1135.Google Scholar
  7. 7.
    Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260–1270.PubMedGoogle Scholar
  8. 8.
    Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375–413.PubMedCrossRefGoogle Scholar
  9. 9.
    Giovannini A, Amato G, Mariotti C, Scassellati-Sforzolini B. Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina 2000;20:37–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Meyer CH, Toth CA. Retinal pigment epithelial tear with vitreo-macular attachment: a novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 2001;239:325–333.PubMedCrossRefGoogle Scholar
  11. 11.
    Bressler NM, Bressler SB, Alexander J, Javornik N, Fine SL, Murphy RP. Loculated fluid. A previously undescribed fluorescein angiographic finding in choroidal neovascularization associated with macular degeneration. Macular Photocoagulation Study Reading Center. Arch Ophthalmol 1991;109:211–215.PubMedGoogle Scholar
  12. 12.
    Ting TD, Oh M, Cox TA, Meyer CH, Toth CA. Decreased visual acuity associated with cystoid macular edema in neo-vascular age-related macular degeneration. Arch Ophthalmol 2002;120:731–737.PubMedGoogle Scholar
  13. 13.
    Gass JDM. Pathophysiologic and histopathologic bases for interpretation of fluorescein angiography. In: Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, 4th ed. St. Louis:Mosby-Year Book, 1997:40–41.Google Scholar
  14. 14.
    Kirber WM, Nichols CW, Grimes PA, Winegrad AI, Laties AM. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol 1980;98:725–728.PubMedGoogle Scholar
  15. 15.
    Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 1985;223:69–76.PubMedCrossRefGoogle Scholar
  16. 16.
    Koenig F, Soubrane G, Coscas G. [Angiographic aspects of senile macular degeneration: spontaneous course] J Fr Ophthalmol 1984;7:93–98.Google Scholar
  17. 17.
    Elman MJ, Fine SL. In: Ryan SJ, ed. Retina: Exudative Age-Related Macular Degeneration, 2nd ed. St. Louis: Mosby, 1994:1071–1102.Google Scholar
  18. 18.
    Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular photocoagulation study group. Arch Ophthalmol 1991;109:1242–1257.Google Scholar
  19. 19.
    Kim SG, Lee SC, Seong YS, Kim SW, Kwon OW. Choroidal neovascularization characteristics and its size in optical coherence tomography. Yonsei Med J 2003;44:821–827.PubMedGoogle Scholar
  20. 20.
    Fernandes LH, Freund KB, Yannuzzi LA, et al. The nature of focal areas of hyperfluorescence or hot spots imaged with indocyanine green angiography. Retina 2002;22:557–568.PubMedCrossRefGoogle Scholar
  21. 21.
    Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416–434.PubMedCrossRefGoogle Scholar
  22. 22.
    Zacks DN, Johnson MW. Retinal angiomatous proliferation: optical coherence tomographic confirmation of an intraretinal lesion. Arch Ophthalmol 2004;122:932–933.PubMedCrossRefGoogle Scholar
  23. 23.
    Zolf R, Glacet-Bernard A, Benhamou N, Mimoun G, Coscas G, Soubrane G. Imaging analysis with optical coherence tomography: relevance for submacular surgery in high myopia and in multifocal choroiditis. Retina 2002;22:192–201.PubMedCrossRefGoogle Scholar
  24. 24.
    Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology 2002;109:1492–1498.PubMedCrossRefGoogle Scholar
  25. 25.
    Rogers AH, Martidis A, Greenberg PB, Puliafito CA. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002;134:566–576.PubMedCrossRefGoogle Scholar
  26. 26.
    Costa RA, Farah ME, Cardillo JA, Calucci D, Williams GA. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 2003;23:159–165.PubMedCrossRefGoogle Scholar
  27. 27.
    Husain D, Kramer M, Kenny AG, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 1999;40:2322–2331.PubMedGoogle Scholar
  28. 28.
    Jaffe GJ, Caprioli J. Related articles, links abstract optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004;137:156–169.PubMedCrossRefGoogle Scholar
  29. 29.
    Moisseiev J, Alhalel A, Masuri R, Treister G. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 1995;113:185–189.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • J. Fernando Arevalo
    • 1
  • Reinaldo A. Garcia
    • 1
  1. 1.Retina and Vitreous Service, Clinica Oftalmológica Centro CaracasArevalo-Coutinho Foundation for Research in OphthalmologyCaracasVenezuela

Personalised recommendations